Barclays lowered the firm’s price target on Varonis (VRNS) to $38 from $45 and keeps an Overweight rating on the shares. The firm updated the company’s model post the earnings report.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis: SaaS Transition Nearing Maturity Drives Long-Term Growth and Attractive Risk-Reward, Justifying Buy Rating
- Balancing Robust SaaS Momentum with Migration Risk: Rationale for Maintaining a Hold on Varonis
- Closing Bell Movers: AMD down 8% on earnings despite beat
- Varonis to acquire AllTrue.ai to manage and secure AI across the enterprise
- Varonis sees FY26 EPS 6c-10c, consensus 34c